| Brand Name | Astrox Pharma |
|---|---|
| Industry Category | Pharmaceutical & Healthcare |
| Business Segment | Medicine Distribution & Pharma Supply |
| Founded Year | 2022 |
| Franchise Started Year | Not specified |
| Headquarters | Not specified |
| Number of Franchise Outlets | 1 to 10 |
Astrox Pharma is a franchise-based business operating in the pharmaceutical distribution sector, supplying medicines and healthcare products to hospitals, medical stores, and wholesale buyers through independently operated units.
The business functions within the healthcare supply chain, focusing on the distribution of packaged pharmaceutical products to institutional and retail buyers.
The business operates as a supply and distribution model within the pharmaceutical industry.
Franchise units act as local distribution centers that procure and supply medicines to healthcare providers and retailers.
Revenue is generated through margins on product distribution and bulk supply transactions.
Franchise outlets are engaged in the distribution of pharmaceutical products.
The model centers on ensuring consistent supply to healthcare-related buyers.
The franchise model enables partners to operate a regional pharmaceutical supply unit under the Astrox Pharma brand.
The franchise operates as a business-to-business (B2B) supply model within the pharmaceutical ecosystem.
The investment level is aligned with inventory-heavy distribution businesses.
Estimated Investment: INR 20 Lakh – 30 Lakh
This cost structure reflects the need for stock management and supply chain operations.
The business requires a larger operational space compared to service-based franchises.
Space Requirement: 1000 – 1500 sq. ft.
Locations with good connectivity to hospitals and retail pharmacies are typically preferred.
Franchise partners receive support related to operational and distribution activities.
This support helps franchisees manage distribution processes efficiently.
The business generates income through product distribution margins.
Estimated Payback Period: 12 months
Profitability depends on distribution volume, product mix, and operational efficiency.
The company was established in 2022 and operates within the pharmaceutical supply and distribution segment.
It currently has a limited number of franchise outlets ranging from 1 to 10, indicating an early-stage expansion phase.
Growth is expected to focus on expanding distribution coverage across different regions.
| Estimated Investment | INR 20 Lakh – 30 Lakh |
|---|---|
| Franchise Fee | Not specified |
| Royalty Fee | Not specified |
| Space Requirement | 1000 – 1500 sq. ft. |
| Payback Period | 12 Months |
| Number of Outlets | 1 to 10 |
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.